Benitec Biopharma

BNTC

Börsenwert 315 Mio. $

#	Name	Position	Handelswert	Veränderung Aktien	Anteils- änderung
1	1 Suvretta Capital Management New York	892.000 $	–	–	–
2	2 Barclays London, United Kingdom	158.000 $	+106.137 $	+4.565	+132 %
3	3 Vanguard Group Malvern, Pennsylvania	91.000 $	–	–	–
4	4 Geode Capital Management Boston, Massachusetts	70.000 $	+1.256 $	+54	+2 %
5	5 Susquehanna International Group Bala Cynwyd, Pennsylvania	62.000 $	+73.703 $	+3.170	Neu
6	6 Citadel Advisors Miami, Florida	58.000 $	+68.332 $	+2.939	Neu
7	7 Virtu Financial New York	55.000 $	+64.822 $	+2.788	Neu
8	8 Millennium Management New York	29.000 $	+34.364 $	+1.478	Neu
9	9 Two Sigma Securities New York	28.000 $	+33.201 $	+1.428	Neu
10	10 State Street Boston, Massachusetts	25.000 $	–	–	–
11	11 Bank of New York Mellon New York	17.000 $	-140 $	-6	-0,7 %
12	WA 12 WealthTrust Axiom Wayne, Pennsylvania	15.000 $	–	–	–
13	13 Northern Trust Chicago, Illinois	14.000 $	–	–	–
14	14 UBS Group Zurich, Switzerland	13.000 $	+15.833 $	+681	+3.405 %
15	15 Morgan Stanley New York	7.000 $	+7.789 $	+335	+5.583 %
16	16 Simplex Trading Chicago, Illinois	7.000 $	+8.347 $	+359	+5.983 %
17	17 Tower Research Capital (TRC) New York	4.000 $	+3.069 $	+132	+140 %
18	18 Citigroup New York	4.000 $	+4.673 $	+201	+20.100 %
19	19 Group One Trading Chicago, Illinois	2.000 $	–	–	–
20	20 Silverarc Capital Management Boston, Massachusetts	–	-57.000 $	-28.993	Geschlossen
21	21 Atom Investors Austin, Texas	–	-87.000 $	-2.196	Geschlossen
22	22 BlackRock New York	–	-46.000 $	-1.150	Geschlossen
23	MHR 23 Matthew Hamilton Rosenberg	–	-1.000 $	-22	Geschlossen
24	24 Fieldpoint Private Securities Greenwich, Connecticut	–	-23 $	-1	Geschlossen

Benitec Biopharma BNTC Börsenwert 315 Mio. $

Benitec Biopharma

BNTC

Börsenwert 315 Mio. $